Kähäri VM - Search Results

1

Keratinocyte growth factor induces gene expression signature associated with suppression of malignant phenotype of cutaneous squamous carcinoma cells.

Toriseva M, Ala-aho R, Peltonen S, Peltonen J, Grénman R, Kähäri VM. Toriseva M, et al. Among authors: kahari vm. PLoS One. 2012;7(3):e33041. doi: 10.1371/journal.pone.0033041. Epub 2012 Mar 12. PLoS One. 2012. PMID: 22427941 Free PMC article.

2

Expression of collagenase-3 (MMP-13) enhances invasion of human fibrosarcoma HT-1080 cells.

Ala-Aho R, Johansson N, Baker AH, Kähäri VM. Ala-Aho R, et al. Among authors: kahari vm. Int J Cancer. 2002 Jan 20;97(3):283-9. doi: 10.1002/ijc.1619. Int J Cancer. 2002. PMID: 11774278

3

Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells.

Ala-aho R, Grénman R, Seth P, Kähäri VM. Ala-aho R, et al. Among authors: kahari vm. Oncogene. 2002 Feb 14;21(8):1187-95. doi: 10.1038/sj.onc.1205198. Oncogene. 2002. PMID: 11850838

4

Antitumor activity and bystander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3.

Ahonen M, Ala-Aho R, Baker AH, George SJ, Grénman R, Saarialho-Kere U, Kähäri VM. Ahonen M, et al. Among authors: kahari vm. Mol Ther. 2002 Jun;5(6):705-15. doi: 10.1006/mthe.2002.0606. Mol Ther. 2002. PMID: 12027554 Free article.

5

Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome.

Kerkelä E, Ala-aho R, Klemi P, Grénman S, Shapiro SD, Kähäri VM, Saarialho-Kere U. Kerkelä E, et al. Among authors: kahari vm. J Pathol. 2002 Oct;198(2):258-69. doi: 10.1002/path.1198. J Pathol. 2002. PMID: 12237887

6

Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation.

Impola U, Toriseva M, Suomela S, Jeskanen L, Hieta N, Jahkola T, Grenman R, Kähäri VM, Saarialho-Kere U. Impola U, et al. Among authors: kahari vm. Int J Cancer. 2003 Mar 1;103(6):709-16. doi: 10.1002/ijc.10902. Int J Cancer. 2003. PMID: 12516088

7

Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo.

Ala-aho R, Ahonen M, George SJ, Heikkilä J, Grénman R, Kallajoki M, Kähäri VM. Ala-aho R, et al. Among authors: kahari vm. Oncogene. 2004 Jul 1;23(30):5111-23. doi: 10.1038/sj.onc.1207678. Oncogene. 2004. PMID: 15094779

8

Collagenases in cancer.

Ala-aho R, Kähäri VM. Ala-aho R, et al. Among authors: kahari vm. Biochimie. 2005 Mar-Apr;87(3-4):273-86. doi: 10.1016/j.biochi.2004.12.009. Biochimie. 2005. PMID: 15781314 Review.

9

Matrix metalloproteinases as therapeutic targets in cancer.

Vihinen P, Ala-aho R, Kähäri VM. Vihinen P, et al. Among authors: kahari vm. Curr Cancer Drug Targets. 2005 May;5(3):203-20. doi: 10.2174/1568009053765799. Curr Cancer Drug Targets. 2005. PMID: 15892620 Review.

10

Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer.

Luukkaa M, Vihinen P, Kronqvist P, Vahlberg T, Pyrhönen S, Kähäri VM, Grénman R. Luukkaa M, et al. Among authors: kahari vm. Head Neck. 2006 Mar;28(3):225-34. doi: 10.1002/hed.20322. Head Neck. 2006. PMID: 16302191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters